Mortality of hemodialysis patients is associated with their clinical situation at the start of treatment

Introduction: Previous reports have shown very high mortality among hemodialyisis patients. Our goal was to analyze the mortality of patients in the Renal Registry of Patients who remained exclusively on hemodialysis treatment. Methods: The cohort of patients who started treatment in the community o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 2021-07, Vol.41 (4), p.461-466
Hauptverfasser: de Arriba, Gabriel, Avila, Gonzalo Gutierrez, Guinea, Marta Torres, Alia, Inmaculada Moreno, Herruzo, Jose Antonio, Ruiz, Begona Rincon, Tejeiro, Rafael Diaz, Rubio, Maria Esperanza Lopez, Poyatos, Carmen Vozmediano, Roldan, Carmina Gomez
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Introduction: Previous reports have shown very high mortality among hemodialyisis patients. Our goal was to analyze the mortality of patients in the Renal Registry of Patients who remained exclusively on hemodialysis treatment. Methods: The cohort of patients who started treatment in the community of Castilla-La Mancha between 2010 and 2012 and remained on hemodialysis treatment was analysed until the end of 2017. Age, sex, primary kidney disease, vascular access, hemoglobin, Charlson index and serum albumin were included. Results: Mortality rate was 63,4% after 5 years and 76% at the end of the study, with no difference between males and females, and was linked to an older age, urgent onset or in those with acute deterioration of chronic kidney disease, the use of catheters or albumin less than 3.5 g/dl. Conclusions: Mortality in patients who remain on hemodialysis is very high and is associated with non-modifiable factors such as age but also others that we can prevent or treat such as type of vascular access or nutrition status at the beginning of treatment. (C) 2021 Sociedad Espanola de Nefrologia. Published by Elsevier Espana, S.L.U.
ISSN:0211-6995
1989-2284
DOI:10.1016/j.nefro.2020.11.006